EXCLI J EXCLI Journal 1611-2156 Leibniz Research Centre for Working Environment and Human Factors 2017-1038 10.17179/excli2017-1038 Doc1321 Editorial material Highlight report: The pseudolobule in liver fibrosis Bolt H.M. * 1 IfADo, Leibniz Research Centre for Working Environment and Human Factors, Dortmund *To whom correspondence should be addressed: H.M. Bolt, IfADo, Leibniz Research Centre for Working Environment and Human Factors, Dortmund, E-mail: bolt@ifado.de 20 12 2017 2017 16 1321 1322 13 12 2017 19 12 2017 Copyright © 2017 Bolt 2017

This is an Open Access article distributed under the terms of the Creative Commons Attribution Licence (http://creativecommons.org/licenses/by/4.0/) You are free to copy, distribute and transmit the work, provided the original author and source are credited.

This article is available from http://www.excli.de/vol16/Bolt_Editorial_20122017_proof.pdf


Recently, Seddik Hammad from Heidelberg University published an interesting report about a frequent misinterpretation in research on liver fibrosis (Hammad et al., 2017[9]): in mice repeated doses of carbontetrachloride (CCl4) cause a pattern of fibrosis, in which pseudolobules occur that are lined by fibrotic streets, which can be visualized by Sirius red staining.

In the center of these pseudolobules vessels can be seen that have been interpreted as central veins. Although the perception that the vessel in the center of the pseudolobule is a central vein may seem intuitively understandable, this clearly represents a misinterpretation. In reality, the vessel in the center of the pseudolobule is a portal vein. In contrast, the central veins are found within the fibrotic streets. This clarification could be achieved by the use of previously established markers that exclusively stain the hepatocytes around the central vein and by specific periportal markers (Hammad et al., 2014[10]). Hammad and colleagues explain the mechanism responsible for this pattern by CCl4 mediated pericentral killing of CYP2E1 positive hepatocytes, which after repeated CCl4 administration leads to fibrotic bridging of pericentral areas (Hammad et al., 2017[9]).

Studies of hepatotoxicity often rely on the correct interpretation of histology (Schenk et al., 2017[18]; Reif et al., 2017[17]; Ghallab et al., 2016[8]; Vartak et al., 2016[20]; Nussler et al., 2014[16]; Drasdo et al., 2014[6]; Campos et al., 2014[3]; Braeuning and Schwarz, 2016[2]; Chen et al., 2015[4]; Crespo Yanguas et al., 2016[5]). Also liver physiology and regeneration depend on optimal zonation (Jansen et al., 2017[12]; Hoehme et al., 2010[11]; Bartl et al., 2015[1]; Yanguas et al., 2016[21]; Stöber, 2016[19]; Moghbel et al., 2016[15]): moreover 3D in vitro systems in toxicology aim for mimicking some of the zonated features of the liver lobule (Frey et al., 2014[7]; Kim et al., 2015[13]; Leist et al., 2017[14]). Therefore, the careful analysis of Hammad and colleagues may help to avoid some misunderstanding in future.

Bartl M Pfaff M Ghallab A Driesch D Henkel SG Hengstler JG Optimality in the zonation of ammonia detoxification in rodent liver Arch Toxicol 2015 89 2069 2078 Braeuning A Schwarz M Is the question of phenobarbital as potential liver cancer risk factor for humans really resolved? Arch Toxicol 2016 90 1525 1526 Campos G Schmidt-Heck W Ghallab A Rochlitz K Pütter L Medinas DB The transcription factor CHOP, a central component of the transcriptional regulatory network induced upon CCl4 intoxication in mouse liver, is not a critical mediator of hepatotoxicity Arch Toxicol 2014 88 1267 1280 Chen RJ Wu HH Wang YJ Strategies to prevent and reverse liver fibrosis in humans and laboratory animals Arch Toxicol 2015 89 1727 1750 Crespo Yanguas S Willebrords J Maes M da Silva TC Veloso Alves Pereira I Cogliati B Connexins and pannexins in liver damage EXCLI J 2016 15 177 186 Drasdo D Hoehme S Hengstler JG How predictive quantitative modelling of tissue organisation can inform liver disease pathogenesis J Hepatol 2014 61 951 956 Frey O Misun PM Fluri DA Hengstler JG Hierlemann A Reconfigurable microfluidic hanging drop network for multi-tissue interaction and analysis Nat Commun 2014 5 4250 Ghallab A Cellière G Henkel SG Driesch D Hoehme S Hofmann U Model-guided identification of a therapeutic strategy to reduce hyperammonemia in liver diseases J Hepatol 2016 64 860–71 Hammad S Braeuning A Meyer C Mohamed FEZA Hengstler JG Dooley S A frequent misinterpretation in current research on liver fibrosis: the vessel in the center of CCl4-induced pseudolobules is a portal vein Arch Toxicol 2017 91 3689 3692 Hammad S Hoehme S Friebel A von Recklinghausen I Othman A Begher-Tibbe B Protocols for staining of bile canalicular and sinusoidal networks of human, mouse and pig livers, three-dimensional reconstruction and quantification of tissue microarchitecture by image processing and analysis Arch Toxicol 2014 88 1161 1183 Hoehme S Brulport M Bauer A Bedawy E Schormann W Hermes M Prediction and validation of cell alignment along microvessels as order principle to restore tissue architecture in liver regeneration Proc Natl Acad Sci U S A 2010 107 10371 10376 Jansen PL Ghallab A Vartak N Reif R Schaap FG Hampe J The ascending pathophysiology of cholestatic liver disease Hepatology 2017 65 722 738 Kim JY Fluri DA Marchan R Boonen K Mohanty S Singh P 3D spherical microtissues and microfluidic technology for multi-tissue experiments and analysis J Biotechnol 2015 205 24 35 Leist M Ghallab A Graepel R Marchan R Hassan R Bennekou SH Adverse outcome pathways: opportunities, limitations and open questions Arch Toxicol 2017 91 3477 3505 Moghbel M Mashohor S Mahmud R Saripan MI Automatic liver segmentation on Computed Tomography using random walkers for treatment planning EXCLI J 2016 15 500 517 Nussler AK Wildemann B Freude T Litzka C Soldo P Friess H Chronic CCl4 intoxication causes liver and bone damage similar to the human pathology of hepatic osteodystrophy: a mouse model to analyse the liver-bone axis Arch Toxicol 2014 88 997 1006 Reif R Ghallab A Beattie L Günther G Kuepfer L Kaye PM In vivo imaging of systemic transport and elimination of xenobiotics and endogenous molecules in mice Arch Toxicol 2017 91 1335 1352 Schenk A Ghallab A Hofmann U Hassan R Schwarz M Schuppert A Physiologically-based modelling in mice suggests an aggravated loss of clearance capacity after toxic liver damage Sci Rep 2017 7 1 6224 Stöber R Pathophysiology of cholestatic liver disease and its relevance for in vitro tests of hepatotoxicity EXCLI J 2016 15 870 871 Vartak N Damle-Vartak A Richter B Dirsch O Dahmen U Hammad S Cholestasis-induced adaptive remodeling of interlobular bile ducts Hepatology 2016 63 951 964 Yanguas SC Cogliati B Willebrords J Maes M Colle I van den Bossche B Experimental models of liver fibrosis Arch Toxicol 2016 90 1025 1048